Navigation Links
Regenerative Medicine Market Expected to Reach $4.5 Billion by 2014
Date:9/1/2010

NEW YORK, Sept. 1 /PRNewswire/ -- TriMark Publications, LLC (http://www.trimarkpublications.com), a global leader in the biotechnology, healthcare and life sciences publishing, cites in its newly published Regenerative Medicine Markets report that the global market for regenerative medicine products will exceed $3 billion in 2010 and is expected to reach $4.5 billion by 2014. Regenerative medicine is a technique to treat injuries and diseases with specially-grown tissues by way of several different methods, including stem cell therapy and tissue engineering.

Before scientific advances such as stem cells, remedies for damaged tissue or organ functions due to congenital deformities, injuries, diseases or simple wear-and-tear relied upon either the body's ability to repair itself (or not) or a surgeon's skilled hands. Now, the area of regenerative medicine promises to revolutionize humanity's ability to remedy countless physical maladies that have afflicted humans and other animals through techniques like stem cells and tissue engineering.

In this study, TriMark Publications reviews the market for regenerative medicine solutions. The areas covered in this study include: available and emerging technologies in the field, the U.S. and global market size for regenerative medicine products, and profiles of companies that are focusing on the regenerative medicine sector.

Reasons to Buy TriMark Content

  • Data is updated regularly in accordance with changes in the industries our reports cover.
  • Information is specifically designed to help individuals who work in the industries the content covers remain competitive in the marketplace.
  • Content contains detailed sales data, market share information and emerging trends, all of which impact the sectors companies focused on biotechnology, life sciences, healthcare, pharmaceuticals and medical devices operate in.
  • Your competitors are buying TriMark content!

About TriMark Publications, LLC

TriMark Publications is a global leader in the biotechnology, healthcare and life sciences publishing. For more information, please visit http://www.trimarkpublications.com.

Important Notice

The statements contained in this news release that are forward-looking are based on current expectations that are subject to a number of uncertainties and risks, and actual results may differ materially.


'/>"/>
SOURCE TriMark Publications, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
2. NeoStem, Inc. to Enter the Regenerative Medicine Market in Asia
3. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
4. Sigma-Aldrich Enters Into Research Collaboration Program With D-Finitive Cell Technologies, Inc., to Develop Research Tools for Regenerative Medicine
5. BIO International Convention 2009: Research Location Germany Presents Potential in Regenerative Medicine
6. Dr. Damien Bates of Organogenesis Speaks on Regenerative Medicine for Opening Night of TEDMED Conference
7. Novocell Receives a Disease Team Award for $20 Million from the California Institute for Regenerative Medicine to Develop a Stem Cell Therapy for the Treatment of Diabetes
8. Stem Cell Assurance Unveils Physician Network Offering Regenerative Cell Cosmetic and Reconstructive Applications
9. Cell Therapy Group Announces Expansion of Consultants Roster in Regenerative Medicine
10. iPierian Awarded Basic Biology Grant by California Institute of Regenerative Medicine to Study Cellular Reprogramming
11. Neuralstem, Inc. to Present At World Stem Cells and Regenerative Medicine Congress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical ... for a host of launch activities including the identification ... this launch activity is especially high in the oncology ... Best Practices and the Role of Medical Affairs ... companies focused on oncology therapies find better ways to ...
(Date:2/5/2016)... , February 5, 2016 Amarantus ... biotechnology company focused on developing products for Regenerative Medicine, ... Rare Pediatric Disease Designation (RPDD) from the US Food ... with MANF. MANF was previously granted orphan drug designation ... --> Amarantus BioScience Holdings, Inc. (OTCQB: ...
(Date:2/4/2016)... ... February 04, 2016 , ... Morf Media Inc ... an interactive FDA compliance training course, Writing Effective SOPs ... accredited interactive course on Morf Playbook—now conveniently available on smartphones and PCs--provides step ...
(Date:2/4/2016)... 2016  Sangamo BioSciences, Inc. (NASDAQ: SGMO ), ... Edward Lanphier , Sangamo,s president and chief executive ... Sangamo,s ZFP Therapeutic ® development programs and an ... ET on Thursday, February 11, 2016, at the Leerink ... conference is being held in New York ...
Breaking Biology Technology:
(Date:1/22/2016)... Jan. 22, 2016 ... of the "Global Biometrics Market in ... offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ...
(Date:1/20/2016)... A market that just keeps on growing. ... explosion in genomics knowledge. Learn all about it in ... of dynamic trends are pushing market growth and company ... pharmacogenomics - pathogen evolution - next generation sequencing - ... understanding of the role of genetic material in Disease ...
(Date:1/20/2016)... Calif. , Jan. 20, 2016  Synaptics ... of human interface solutions, today announced sampling of ... solution for wearables and small screen applications including ... as printers. Supporting round and rectangular shapes, as ... offers excellent performance with moisture on screen, while ...
Breaking Biology News(10 mins):